{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:49:42Z","timestamp":1773661782369,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0022-1759(02)00189-8","type":"journal-article","created":{"date-parts":[[2002,9,10]],"date-time":"2002-09-10T03:19:07Z","timestamp":1031627947000},"page":"131-140","source":"Crossref","is-referenced-by-count":104,"title":["Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories\u2122"],"prefix":"10.1016","volume":"268","author":[{"given":"Thomas G","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Feuerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerold","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Schuler-Thurner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0022-1759(02)00189-8_BIB1","first-page":"6451","article-title":"Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine","volume":"61","author":"Banchereau","year":"2001","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/S0022-1759(02)00189-8_BIB2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0092-8674(01)00448-2","article-title":"Dendritic cells as vectors for therapy","volume":"106","author":"Banchereau","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(96)00079-8","article-title":"Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood","volume":"196","author":"Bender","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB4","first-page":"17","article-title":"Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use","volume":"40","author":"Bernard","year":"1998","journal-title":"Hematol. Cell Ther."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","article-title":"Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells","volume":"193","author":"Dhodapkar","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-1759(00)00269-6","article-title":"A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use","volume":"245","author":"Feuerstein","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB7","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1073\/pnas.141226398","article-title":"Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy","volume":"98","author":"Fong","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1537-2995.2001.41010117.x","article-title":"Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanoma","volume":"41","author":"Glaser","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB12","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.1323","article-title":"A comparison of two types of dendritic cells as adjuvants for the induction of melanoma-specific T cell responses in humans following intranodal injection","volume":"93","author":"Jonuleit","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cyto.990110203","article-title":"High gradient magnetic cell separation with MACS","volume":"11","author":"Miltenyi","year":"1990","journal-title":"Cytometry"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","article-title":"Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability","volume":"196","author":"Romani","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB17","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.165.6.3492","article-title":"Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells","volume":"165","author":"Schuler-Thurner","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20012100","article-title":"Rapid induction of type one helper T cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells","volume":"195","author":"Schuler-Thurner","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.1503","article-title":"Active immunization against cancer with dendritic cells: the near future","volume":"94","author":"Steinman","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/146532401753277184","article-title":"Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC","volume":"3","author":"Suen","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/S0022-1759(02)00189-8_BIB21","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","article-title":"Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma","volume":"190","author":"Thurner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0022-1759(02)00189-8_BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(98)00208-7","article-title":"Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application","volume":"223","author":"Thurner","year":"1999","journal-title":"J. Immunol. Methods"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175902001898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175902001898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T20:56:40Z","timestamp":1554929800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175902001898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0022175902001898"],"URL":"https:\/\/doi.org\/10.1016\/s0022-1759(02)00189-8","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}